News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2006 on August 7, 2006

BOULDER, Colo., July 31 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the fourth quarter and full year of fiscal 2006 on Monday, August 7, 2006, at 4:30 p.m. eastern time and hold a conference call on Tuesday, August 8, 2006, at 9:00 a.m. eastern time. Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief Financial Officer, will lead the call.

Conference Call Information
Date: Tuesday, August 8, 2006
Time: 9:00 a.m. eastern time
Toll-Free: (800) 474-8920
Toll: (719) 457-2727
Pass Code: 4349418
Web Cast: www.arraybiopharma.com

There will be a replay of the conference call for one week, which can be accessed in the United States by dialing toll-free (888) 203-1112, and outside the United States (719) 457-0820. The access code is 4349418. Replay of the call will also be available as a web cast on Array's web site at www.arraybiopharma.com.

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies access Array's drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

SOURCE Array BioPharma Inc.
07/31/2006

CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, or
thaugeto@arraybiopharma.com
Web site: http://www.arraybiopharma.com
(ARRY)
CO: Array BioPharma Inc. ST: Colorado IN: BIO MTC SU: CCA BS-MC -- CLM521 -- 2826 07/31/2006 17:07 EDT http://www.prnewswire.com